http://collegeessayswriting.com/where-to-get-narrative-essay-topics/
Houston-based ITS said it also has expanded its ongoing collaborative relationship with through completiom of additional production services forthat company. Aggregatr proceeds to ITS from these contracts totakl morethan $1 million. Unde r the terms of thes new agreements, ITS will produc high-grade biologics for use in clinical trialsz for several types ofcancer “The signing and execution of these new manufacturingy agreements provide tremendous validation for ITS and the manufacturinyg services that we offer to leading companies and academic institutions in the area of drug development and said David Enloe, ITS president and chief executivr officer.
, an Austin-based biopharmaceutical company that is the parenftof ITS, filed for Chapter 11 bankruptcy protectioj in December. As part of its restructurin g effort, Introgen said it hopesd to sell its therapeutic producg portfolio and reorganize around its contract manufacturing businessin
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment